Literature DB >> 7926722

The DCC gene product in cellular differentiation and colorectal tumorigenesis.

L Hedrick1, K R Cho, E R Fearon, T C Wu, K W Kinzler, B Vogelstein.   

Abstract

The analysis of human colorectal tumors has revealed frequent loss of heterozygosity (LOH) of the long arm of chromosome 18. A novel gene, DCC (deleted in colorectal cancer), located within the region of LOH on chromosome 18q was identified and has been implicated as a tumor suppressor gene. We have now shown that DCC encodes a membrane-bound protein of the immunoglobulin-CAM family, as demonstrated by cell-surface labeling, immunohistochemical analysis, and sequencing of cDNA clones. The DCC protein was found in axons of the central and peripheral nervous system and in differentiated cell types of the intestine. Colorectal tumors that lost their capacity to differentiate into mucus producing cells uniformly lacked DCC expression and loss of a chromosome 18q allele was often accompanied by loss of DCC expression in colon tumors. These results provide evidence that DCC encodes a cell surface-localized protein and emphasize the inverse relationship between differentiation and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926722     DOI: 10.1101/gad.8.10.1174

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  40 in total

1.  Widespread expression of netrin-1 by neurons and oligodendrocytes in the adult mammalian spinal cord.

Authors:  C Manitt; M A Colicos; K M Thompson; E Rousselle; A C Peterson; T E Kennedy
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  Cloning, expression and localization of human BM88 shows that it maps to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesis.

Authors:  M Gaitanou; P Buanne; C Pappa; N Georgopoulou; A Mamalaki; F Tirone; R Matsas
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

Review 3.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

Review 4.  The cellular basis of metastasis.

Authors:  P Ruiz; U Günthert
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

5.  The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation.

Authors:  C Forcet; X Ye; L Granger; V Corset; H Shin; D E Bredesen; P Mehlen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

6.  Loss of DCC expression in astrocytomas: relation to p53 abnormalities, cell kinetics, and survival.

Authors:  A Hara; M Saegusa; T Mikami; I Okayasu
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

7.  Human colon cancer cells deficient in DCC produce abnormal transcripts in progression of carcinogenesis.

Authors:  S Huerta; E S Srivatsan; N Venkatasan; E H Livingston
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

Review 8.  Is there a genetic signature for liver metastasis in colorectal cancer?

Authors:  Cristina Nadal; Joan Maurel; Pere Gascon
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

Review 9.  The pathogenesis of port-site recurrences.

Authors:  M A Reymond; C Schneider; S Kastl; W Hohenberger; F Köckerling
Journal:  J Gastrointest Surg       Date:  1998 Sep-Oct       Impact factor: 3.452

Review 10.  DCC mutation update: Congenital mirror movements, isolated agenesis of the corpus callosum, and developmental split brain syndrome.

Authors:  Ashley P L Marsh; Timothy J Edwards; Charles Galea; Helen M Cooper; Elizabeth C Engle; Saumya S Jamuar; Aurélie Méneret; Marie-Laure Moutard; Caroline Nava; Agnès Rastetter; Gail Robinson; Guy Rouleau; Emmanuel Roze; Megan Spencer-Smith; Oriane Trouillard; Thierry Billette de Villemeur; Christopher A Walsh; Timothy W Yu; Delphine Heron; Elliott H Sherr; Linda J Richards; Christel Depienne; Richard J Leventer; Paul J Lockhart
Journal:  Hum Mutat       Date:  2017-11-11       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.